Axsome Therapeutics (NASDAQ: AXSM)
Axsome Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Axsome Therapeutics Company Info
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
News & Analysis
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Today's market loser could be tomorrow's market winner.
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
There's lots of upside potential for these drugmakers.
Why Shares of Axsome Therapeutics Fell Wednesday
The biopharmaceutical company announced a $225 million stock sale.
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock
Markets could have a tough time building on gains from Tuesday.
2 Under-the-Radar Biotech Stocks to Buy in 2023
These companies are coming into their own.
Where Will Axsome Therapeutics Be in 3 Years?
The stock soared more than 100% last year.
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now?
Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics.
Valuation
Earnings Transcripts
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript
AXSM earnings call for the period ending December 31, 2023.
Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript
AXSM earnings call for the period ending September 30, 2023.
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
AXSM earnings call for the period ending June 30, 2023.
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
AXSM earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.